sch 23982 has been researched along with raclopride in 2 studies
Studies (sch 23982) | Trials (sch 23982) | Recent Studies (post-2010) (sch 23982) | Studies (raclopride) | Trials (raclopride) | Recent Studies (post-2010) (raclopride) |
---|---|---|---|---|---|
87 | 0 | 0 | 1,802 | 132 | 419 |
Protein | Taxonomy | sch 23982 (IC50) | raclopride (IC50) |
---|---|---|---|
D(2) dopamine receptor | Homo sapiens (human) | 0.052 | |
D(2) dopamine receptor | Mus musculus (house mouse) | 0.032 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coirini, H; Johnson, AE; Källström, L; Wiesel, FA; Yu, J | 1 |
Ferré, S; Fredholm, BB; Fuxe, K; Lillrank, SM; Lipska, BK; Weinberger, DR | 1 |
2 other study(ies) available for sch 23982 and raclopride
Article | Year |
---|---|
Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Topics: Animals; Autoradiography; Basal Ganglia; Benzazepines; Dopamine Antagonists; Female; Gene Expression Regulation; Iodine Radioisotopes; Kinetics; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; RNA, Messenger; Salicylamides; Substantia Nigra; Transcription, Genetic | 1998 |
Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
Topics: Animals; Animals, Newborn; Antipsychotic Agents; Benzazepines; Corpus Striatum; Disease Models, Animal; Dopamine Antagonists; Female; Hippocampus; Male; Pregnancy; Purinergic P1 Receptor Antagonists; Pyrimidines; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Salicylamides; Schizophrenia; Triazoles; Xanthines | 1999 |